Disclosure Information

In accordance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all financial relationships with any commercial interest (termed by the ACCME as “ineligible companies”, defined below) held in the last 24 months (see below for definitions). Please note that first authors were required to collect and submit disclosure information on behalf all other authors/contributors, if applicable.

Ineligible company

The ACCME defines an “ineligible company” as any entity producing, marketing, re-selling, or distributing health care goods or services used on or consumed by patients. Providers of clinical services directly to patients are NOT included in this definition.

Financial Relationships

Relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit.  Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected.  

Conflict of Interest

Circumstances create a conflict of interest when an individual has an opportunity to affect CME content about products or services of an ineligible company with which he/she has a financial relationship.

The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the educational activity.  Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during the educational activity, please report it on the evaluation. 

American College of Surgeons Faculty Disclosures

ADMR Planning Committee:

Susan Miller Briggs, MD, MPH, FACS
No disclosures

David V. Shatz, MD, FACS
No disclosures

David. P. Blake, MD, MPH, DMCC, FACS, FACHE, FSIS
No disclosures

ADMR Subject Medical Experts:

Christopher T. Born MD, FACS, FAAOS, FIOTA
BioIntraface, Stockholder, Board of Directors, Chief Medical Officer
BI Medical, Stockholder, Chief Medical Officer
IlluminOss, Consultant Fees, Chief Medical Officer
Stryker Orthopaedics, Royalties, Product Designer

Mark W. Bowyer MD, FACS, FRCS (Glasg) FRCS-hon (Thailand), DMCC
No disclosures

Eric H. Bradburn, DO, MS, FACS
No disclosures

Marko Bukur, MD, FACS
Zimmer Biomet, Consulting Fees, Educator/Consultant

Eileen Bulger, MD, FACS
No disclosures

Jeannette Capella, MD, MEd, FACS
No disclosures

Jay Doucet MD, MSc, FRCSC, FACS, RDMS
No disclosures

Alexander L. Eastman, MD, MPH, FACS, FAEMS
No disclosures

Mary E. Fallat MD, FACS
No disclosures

Adam D. Fox DO, FACS
Teleflex, Consulting Fees, Medical Advisory Board

Annekathryn Goodman, MD, MPH, MA, MS, FACS, FACOG
No disclosures

Sharon Henry MD, FACS
No disclosures

John B. Holcomb MD, FACS
Aspem Medical, Salary, Consultant
CCJ Medical, Equity, Board member
Decisio Health, Equity, Board member
Hemostatics, Equity, Board member
QinFlow, Equity, Board member
WFIRM, Salary, Consultant
Zibrio, Equity, Board member

Donald H. Jenkins MD, FACS
No disclosures

David F. Lawlor MD, FACS, FRCSC
Zim Vie, Honoraria, Lecturer
Highridge Medical, Honoraria, Lecturer

Manuel Lorenzo MD, MBA, FACS, FCCM
No disclosures

Tina L. Palmieri MD, FACS, FABA, MCCM
No disclosures

Gerd Daniel Pust, MD, MBA, FACS, FCCM, DABS
No disclosures

A. Tyler Putnam, II, MD, FACS, FCCM
No disclosures

Kyle N. Remick, MD, FACS
No disclosures

Peter Rhee MD, MPH, FACS, FCCM, DMCC
No disclosures

Martin A. Schreiber MD, FACS, FCCM
CSL Behring, Institutional Support, Advisory Panel Member
Haemonetics, Institutional Support, Advisory Panel Member

John T. Schulz III, MD, PhD, FACS
No disclosures

Robert L. Sheridan, MD, FACS
No disclosures

Jeffrey S. Upperman, MD, FACS, FAAP
No disclosures

ADMR Consultants:

Edward (Ted) M. Kennedy, EdD
No disclosures

Julie Cwik, MSEd, MSLIS
No disclosures